Biologics patent protection provision pulled from Trump trade deal 17-Dec-2019 By Nick Taylor The Trump Administration removes biologics patent provision from North American trade deal.
Alnylam settles ‘inherently unpredictable’ patent litigation over Onpattro 19-Dec-2018 By Maggie Lynch Alnylam settled its patent litigation with Silence Therapeutics, after an ongoing litigation regarding patent infringement of Silence’s RNAi therapy.